Literature DB >> 9546061

Normal and rearranged PAX3 expression in human rhabdomyosarcoma.

E Frascella1, L Toffolatti, A Rosolen.   

Abstract

PAX3, a member of the PAX-gene family, encodes a nuclear transcription factor that is transiently expressed in the neural tube and in muscle progenitor cells and regulates embryonal development in the mouse. Together with the FKHR gene it is involved in the t(2;13)(q35;q14), a specific translocation associated with alveolar rhabdomyosarcoma (ARMS). As a consequence of the rearrangement two chimeric transcripts originate: FKHR-PAX3 and PAX3-FKHR. We studied the expression of wild type PAX3 and the chimeric transcripts originating from the t(2;13) in a series of 23 rhabdomyosarcomas (RMS) of childhood, by reverse transcriptase polymerase chain reaction (RT-PCR). Wild type PAX3 was detected in 48% of the RMS, whereas another 39% were positive only after nested PCR. Normal adult-skeletal muscle showed a very weak expression of PAX3, but fetal muscle did not express PAX3. PAX3-FKHR was found in 11 of 15 alveolar RMS, 7 of which were positive also for the reciprocal transcript, whereas no RMS expressed FKHR-PAX3 alone. These results confirm that the PAX3-FKHR transcript is specifically associated with the alveolar RMS and that it is a more sensitive marker of the t(2;13) than the reciprocal product FKHR-PAX3. Furthermore, the finding of PAX3 expression with or without PAX3-FKHR transcript in the great majority of the cases raises the question of whether PAX3 expression could play a role in the pathogenesis of RMS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546061     DOI: 10.1016/s0165-4608(97)00352-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

Review 1.  Childhood rhabdomyosarcoma: recent advances and prospective views.

Authors:  C Wang
Journal:  J Dent Res       Date:  2011-09-13       Impact factor: 6.116

2.  Clinical significance and prognostic value of PAX3 expression in human glioma.

Authors:  Jian Chen; Liang Xia; Xiujie Wu; Liqin Xu; Dekang Nie; Jinlong Shi; Xide Xu; Lanchun Ni; Shaoqing Ju; Xinhua Wu; Hui Zhu; Wei Shi
Journal:  J Mol Neurosci       Date:  2012-01-10       Impact factor: 3.444

3.  Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

Authors:  Charles Keller; Benjamin R Arenkiel; Cheryl M Coffin; Nabeel El-Bardeesy; Ronald A DePinho; Mario R Capecchi
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

Review 4.  Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Authors:  N J Sebire; M Malone
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

5.  Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.

Authors:  Qiande Hu; Yewen Yuan; Chiayeng Wang
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

6.  PAX Genes in Cancer; Friends or Foes?

Authors:  Caiyun G Li; Michael R Eccles
Journal:  Front Genet       Date:  2012-01-31       Impact factor: 4.599

Review 7.  Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice.

Authors:  Chiara Agnoletto; Chiara Caruso; Cecilia Garofalo
Journal:  Cancers (Basel)       Date:  2021-05-02       Impact factor: 6.639

8.  PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.

Authors:  Wei Liu; Fang Sui; Jiazhe Liu; Meichen Wang; Sijia Tian; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Oncotarget       Date:  2016-08-23

9.  Transcriptional Repression of p53 by PAX3 Contributes to Gliomagenesis and Differentiation of Glioma Stem Cells.

Authors:  Hui Zhu; Hongkui Wang; Qingfeng Huang; Qianqian Liu; Yibing Guo; Jingjing Lu; Xiaohong Li; Chengbin Xue; Qianqian Han
Journal:  Front Mol Neurosci       Date:  2018-06-08       Impact factor: 5.639

Review 10.  Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma.

Authors:  Thanh Hung Nguyen; Frederic G Barr
Journal:  Molecules       Date:  2018-10-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.